We are live on ! Find out more
KPP

Kings Path Partners Portfolio holdings

AUM $376M
1-Year Est. Return 19%
This Fund
S&P 500
This Quarter Est. Return
+0.02%
1 Year Est. Return
+19%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$212M
AUM Growth
Cap. Flow
+$211M
Cap. Flow %
99.46%
Top 10 Hldgs %
43.46%
Holding
282
New
282
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 8.66%
2 Technology 4.87%
3 Consumer Discretionary 4.44%
4 Consumer Staples 3.94%
5 Financials 3.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VITL icon
76
Vital Farms
VITL
$558M
$753K 0.35%
+16,100
New +$555K
TFIN icon
77
Triumph Financial Inc
TFIN
$1.83B
$728K 0.34%
+8,909
New +$664K
STZ icon
78
Constellation Brands
STZ
$22.2B
$699K 0.33%
+2,716
New +$699K
AVUV icon
79
Avantis US Small Cap Value ETF
AVUV
$29.7B
$696K 0.33%
+7,761
New +$703K
MCB icon
80
Metropolitan Bank Holding Corp
MCB
$1.13B
$683K 0.32%
+16,220
New +$649K
BOOT icon
81
Boot Barn
BOOT
$4.55B
$682K 0.32%
+5,288
New +$595K
IVV icon
82
iShares Core S&P 500 ETF
IVV
$876B
$676K 0.32%
+1,236
New +$650K
VONV icon
83
Vanguard Russell 1000 Value ETF
VONV
$20.4B
$660K 0.31%
+8,621
New +$662K
RPAY icon
84
Repay Holdings
RPAY
$315M
$660K 0.31%
+62,496
New +$639K
KDP icon
85
Keurig Dr Pepper
KDP
$40.4B
$659K 0.31%
+19,741
New +$655K
SRI icon
86
Stoneridge
SRI
$209M
$657K 0.31%
+41,180
New +$659K
FNDF icon
87
Schwab Fundamental International Large Company Index ETF
FNDF
$24.3B
$643K 0.3%
+18,348
New +$651K
TILT icon
88
FlexShares Morningstar US Market Factors Tilt Index Fund
TILT
$2.17B
$591K 0.28%
+2,955
New +$577K
MLAB icon
89
Mesa Laboratories
MLAB
$539M
$588K 0.28%
+6,776
New +$710K
LGND icon
90
Ligand Pharmaceuticals
LGND
$6.02B
$580K 0.27%
+6,880
New +$547K
UTMD icon
91
Utah Medical Products
UTMD
$214M
$568K 0.27%
+8,509
New +$579K
EPM icon
92
Evolution Petroleum
EPM
$137M
$566K 0.27%
+107,430
New +$603K
NSSC icon
93
Napco Security Technologies
NSSC
$1.28B
$554K 0.26%
+10,664
New +$488K
INFU icon
94
InfuSystem Holdings
INFU
$184M
$514K 0.24%
+75,289
New +$553K
ALNT icon
95
Allient
ALNT
$1.47B
$508K 0.24%
+20,115
New +$576K
SCHR
96
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.2B
$505K 0.24%
+20,694
New +$501K
IBDP
97
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
$503K 0.24%
+20,015
New +$502K
CRMT icon
98
America's Car Mart
CRMT
$25.3M
$468K 0.22%
+7,767
New +$469K
NVEC icon
99
NVE Corp
NVEC
$569M
$443K 0.21%
+5,925
New +$464K
PRO
100
DELISTED
PROS Holdings
PRO
$392K 0.18%
+13,695
New +$435K

Similar funds

Kings Path Partners's Q2 2024 Portfolio in Review

Q2 2024 is the first quarter with a 13F filing on record for Kings Path Partners, which disclosed 282 positions worth $212M. Its ten largest holdings account for 43% of the portfolio.

Its largest position is Vanguard Total Stock Market ETF: 67,825 shares worth $18.1M.

By sector, the portfolio is most concentrated in Healthcare at 8.7% of assets, followed by Technology and Consumer Discretionary.

  • Kings Path Partners's largest Q2 2024 buy was Vanguard Total Stock Market ETF: 67,825 shares worth $18.1M.
  • Kings Path Partners's ten largest holdings make up 43% of its $212M portfolio in Q2 2024.
  • Kings Path Partners disclosed 282 positions in Q2 2024, its first 13F filing on record.

Based on Kings Path Partners's 13F filing for Q2 2024, filed 30 Jul 2024.